BOSTON (TheStreet) -- Santarus (SNTS) was one of several stocks trading below $5 poised to move on above-average volume Thursday after the biopharmaceutical company struck a licensing deal for a Type 2 diabetes drug..
reached terms for the exclusive manufacturing and commercial rights to Cycloset tablets in the U.S. with privately held companies S2 Therapeutics and VeroScience LLC. Santarus will pay an upfront $5 million fee, and then pay certain product royalties to S2 and VeroScience while recording all Cycloset sales.
Shares of Santarus jumped by 33 cents, or 14.9%, to $2.55 in Wednesday's late trading session. The average daily share volume for Santarus is 309,000.
climbed by 34 cents, or 7%, to $5.23 in the premarket session after Sierra Sciences said it has co-authored a paper announcing the first compound that activates the enzyme telomerase in the human body, which it called a critical prerequisite for technology that could stop or reverse the aging process. Geron, TA Sciences, PhysioAge, and the Spanish National Cancer Research Center collaborated on the effort. The average daily share volume for Geron is 1.4 million.
On the downside,
( CHP) dropped by 6 cents, or 13.6%, to 37 cents in Wednesday's after-market session after the integrated reserve power systems company postponed filing its second-quarter report as it doesn't have enough time to analyze the presence of impairment indicators and determine the amount of the goodwill impairment charges.
C&D Technologies said it expects to report second-quarter results on or before Sept. 14. The average daily share volume for C&D Technologies is 330,000.
shares will likely see increased trading volume after the systems integration and consulting company said it has been awarded $4.9 million in several contracts over a one-year time period from the U.S. Air Force, the Defense Technology Security Administration, and other State government and commercial accounts.
ATS also announced a settlement with the former principal owners of Advanced Technology Systems, where ATS received a settlement payment of $1.25 million. The average daily share volume for ATS is only 7,000.
-- Written by Robert Holmes in Boston
>To contact the writer of this article, click here:
>To follow Robert Holmes on Twitter, go to
>To submit a news tip, send an email to:
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.